Skip to main content
Log in

Therapeutic value of anticholinergic agents in chronic obstructive pulmonary diseases

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Anticholinergic agents have proved to be powerful bronchodilating drugs in various types of chronic obstructive pulmonary disease. Atropine given as an aerosol had a stronger bronchodilating effect, even in low doses not producing side-effects, than after peroral or intramuscular administration. Sch 1000, a new quater-nized atropine derivative had a stronger and more prolonged bronchodilator effect, even in significantly lower doses, and no side effects were observed. Because of its adventageous characteristics, Sch 1000 seems to be the anticholinergic agent to be preferred in clinical practice. It shows a wider therapeutic range than the beta adrenergic agent orciprenaline. A vagus-mediated reflex mechanism may be involved in histamine-induced bronchoconstriction. Experimental results show that a cholinergic mechanism and increased parasympathetic tone are important factors in the pathological mechanism of chronic airways obstruction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bauer, R., Wick, H.: Ipratropium-bromid (Sch 1000) als Aerosol — ein Anticholinergikum zur Behandlung obstruktiver Atemwegserkrankungen. In: Tagungsberichte vom ersten Internationalen Kongress für Aerosole in der Medizin. 19. – 21. 9. 1973, S. 333 – 346, Baden/Wien

  2. Bauer, R., Kulm, F.S., Stockhaus, K., Wick, H.: Exposé über Sch 1000, Magensekretionshemmer und Spasmolytikum. In: Biologische Forschung-Pharmakologie. Ingelheim/Rh.: C.H. Boehringer Sohn 1968

    Google Scholar 

  3. Cabezas, G.A., Graf, P.D., Nadel, J.A.: Sympathetic versus parasympathetic nervous regulation of airways in dogs. J. appl. Physiol.31, 651–665 (1971)

    Google Scholar 

  4. Chamberlain, D.A., Muir, D.C.F., Kennedy, K.P.: Atropine methonitrate and isoprenalin in bronchial asthma. Lancet1962 II, 1019–1021

    Google Scholar 

  5. Colebatch, H.J.H., Halmágyi, D.F.J.: Effect of vagotomy and vagal stimulation on lung mechanics and circulation. J. appl. Physiol.18, 881–887 (1963)

    Google Scholar 

  6. Du Bois, A.B., Dautrebande, L.: Acute effects of breathing inert dust particles and of carbachol aerosol on the mechanical characteristics of the lungs in man. Changes in response after inhaling sympathomimetic aerosols. J. clin. Invest.37, 1746–1755 (1958)

    Google Scholar 

  7. Galgóczy, G., Mandi, A., Jancsó, T.: Comparative examination of some broncholytic substances in chronic obstructive bronchitis. Pneumonologie148, 89–97 (1973)

    Google Scholar 

  8. Gayrard, P., Orehek, J., Charpin, J.: Effects bronchodilatateurs d'un atropinique de synthèse: Sch 1000, aerosol-doseur. Rev. franç. Mal. Resp.1, 481–492 (1973)

    Google Scholar 

  9. Goodman, L.S., Gilman, A.: The pharmacological basis of therapeutics. New York: McMillan 1965

    Google Scholar 

  10. Grewal, P.S.: Behandlung der obstruktiven Bronchitis mit einem Tropasäureester (Sch 1000. Diss. Münster 1969

    Google Scholar 

  11. Iravani, J., Schüler, K.G.: In vitro Untersuchungen der Bronchomotorik der Ratte. Pneumonologie144, 253–265 (1971)

    Google Scholar 

  12. Iravani, J.: Wirkung einiger bronchodilatierender Substanzen auf die Flimmeraktivität unter besonderer Berücksichtigung von Berotec®. Suppl. Internat. J. clin. Pharmacol.4, 20–24 (1971)

    Google Scholar 

  13. Islam, M.S., Rasche, B., Vastag, E., Ulmer, W.T.: Empfindlichkeitssteigerung der Bronchialmuskulatur durch proteolytische Fermente im Sputum. Pneumonologie146, 232–240 (1971)

    Google Scholar 

  14. Islam, M.S., Vastag, E., Ulmer, W.T.: Sulfurdioxide induced bronchial hyperreactivity against acetylcholine. Int. Arch. Arbeitsmed.29, 221–232 (1972)

    Google Scholar 

  15. Islam, M.S., Ulmer, W.T.: Der Wirkungsmechanismus von Serotonin (5-Hydroxytryptamin) und Histamin bei der Atemwegsobstruktion. Respiration30, 360–377 (1973)

    Google Scholar 

  16. Islam, M.S., Rasche, B., Vastag, E., Ulmer, W.T.: Über den Wirkungsmechanismus von Histamin in den Atemwegen. Respiration29, 538–548 (1972)

    Google Scholar 

  17. Itkin, J.H., Anand, S.C.: The role of atropine as a mediator blocker of induced bronchial obstruction. J. Allergy45, 178–186 (1970)

    Google Scholar 

  18. Kaliner, M., Orange, R.P., LaRaia, P.J., Austen, K.F.: Cholinergic enhancement of the immunologic release of histamine and slow-reacting substance of anaphylaxis (SRS-A) from human lung tissue. J. All. clin. Immunol.49, 88–89 (1972)

    Google Scholar 

  19. Kersten, W.: Protektive Wirkung von Ipratropiumbromid (Sch 1000) bei akuten Bronchokonstriktionen durch Allergeninhalation. Respiration31, 412–417 (1974)

    Google Scholar 

  20. Kock, M.A. de, Nadel, J.A., Zwi, S.: New method for perfusing bronchial arteries: Histamine bronchoconstriction and apnea. J. appl. Physiol.21, 185–194 (1966)

    Google Scholar 

  21. MacDonald, A.G., Ingram, C.G., McNeill, R.S.: The effect of propranolol on airway resistance. Brit. J. Anaesth.39, 919–926 (1967)

    Google Scholar 

  22. McNeill, R.S.: Effect of a beta-adrenergic blocking agent, propranolol, on asthmatics. Lancet1964 II, 1101–1102

    Google Scholar 

  23. Nadel, J.A., Widdicombe, J.G.: Effect of changes in blood gas tensions and carotid sinus pressure on tracheal volume and total lung resistance to airflow. J. Physiol.163, 13–33, (1962)

    Google Scholar 

  24. Nadel, J.A., Salem, A., Tamplin, B., Tokiwa, Y.: Mechanism of bronchoconstriction during inhalation of sulfur dioxide. J. appl. Physiol.20, 164–167 (1965)

    Google Scholar 

  25. Nadel, J.A., Widdicombe, J.G.: Reflex effects of upper airway irritation on total lung resistance and blood pressure. J. appl. Physiol.17, 861–865 (1962)

    Google Scholar 

  26. Nadel, J.A., Comroe, J.H.: Acute effects of inhalation of cigarette smoke on airway conductance. J. appl. Physiol.16, 713–716 (1961)

    Google Scholar 

  27. Nadel, J.A.: Structure-function relationships in the airways: Bronchoconstriction mediated via vagus nerves or bronchial arteries; peripheral lung constriction mediated via pulmonary arteries. Med. Thorac.22, 231–242 (1965)

    Google Scholar 

  28. Olsen, C.R., Colebatch, H.J.H., Mebel, P.E., Nadel, J.A., Staub, N.C.: Motor control of pulmonary airways studied by nerve stimulation. J. appl. Physiol.20, 202–208 (1965)

    Google Scholar 

  29. Poppius, H., Salorinne, Y., Viljanen, A.A.: Inhalation of a new anticholinergic drug, Sch 1000, in asthma and chronic bronchitis. Bull. Physio-path. Resp.8, 643–652 (1972)

    Google Scholar 

  30. Preisig, R.: The pharmacological basis of bronchospasmolytic agents. Respiration26, 95–102 (1965)

    Google Scholar 

  31. Reichel, G.: Chronische Bronchitis. Therapie-woche15, 610–615 (1970)

    Google Scholar 

  32. Simonsson, B.G., Jakobs, F.M., Nadel, J.A.: Role of autonomic nervous system and the cough reflex in the increased responsiveness of airway in patients with obstructive airway disease. J. clin. Invest.46, 1812–1818 (1967)

    Google Scholar 

  33. Sterling, G.M.: The mechanism of bronchoconstriction due to hypocapnia in man. Clin. Sci.34, 277–285 (1969)

    Google Scholar 

  34. Sterling, G.M.: The mechanism of bronchoconstriction due to hypoxia in man. Clin. Sci.35, 105–114 (1968)

    Google Scholar 

  35. Sterling, G.M., Batten, J.C.: Effect of aerosol propellants and surfactants on airway resistance. Thorax24, 228–231 (1969)

    Google Scholar 

  36. Thurlbeck, W.M., Henderson, J.A., Fraser, R.G., Bates, D.V.: Chronic obstructive lung disease. A comparison between clinical, roentgenologic, functional and morphologic criteria in chronic bronchitis, emphysema, asthma and bronchiectasis. Medicine (Baltimore)49, 81–145 (1970)

    Google Scholar 

  37. Ulmer, W.T., Dorsch, J., Iravani, J., Schüler, K.G., Stempel, G., Vastag, E.: Anticholinergika als Bronchodilatatoren. Arzneimittel-Forsch. (Drug Res.)23, 468–471 (1973)

    Google Scholar 

  38. Ulmer, W.T.: Inhalationstherapie mit Atropinderivaten. Med. Klin.66, 326–329 (1971)

    Google Scholar 

  39. Widdicombe, J.G.: Action potentials in parasympathetic and sympathetic efferent fibres to the trachea and lungs of dogs and cats. J. Physiol.186, 56–88 (1966)

    Google Scholar 

  40. Widdicombe, J.G., Kent, D.C., Nadel, J.A.: Mechanism of bronchoconstriction during inhalation of dust. J. appl. Physiol.17, 613–616 (1962)

    Google Scholar 

  41. Widdicombe, J.G., Sterling, G.M.: The autonomic nervous system and breathing. Arch. intern. Med.126, 311–329 (1970)

    Google Scholar 

  42. Widdicombe, J.G., Nadel, J.A.: Reflex effects of lung inflation on tracheal volume. J. appl. Physiol.18, 681–686 (1963)

    Google Scholar 

  43. Yu, D.Y.C., Galant, S.P., Gold, W.M.: Inhibition of antigen-induced bronchoconstriction by atropine in asthmatic patients. J. appl. Physiol.32, 823–828 (1972)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vastag, E., Nagy, L. & Miskovits, G. Therapeutic value of anticholinergic agents in chronic obstructive pulmonary diseases. Eur J Clin Pharmacol 10, 201–208 (1976). https://doi.org/10.1007/BF00558330

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558330

Key words

Navigation